A phase I/II study of capecitabine (X), irinotecan (I) and oxaliplatin (O) as first-line therapy in patients (PTS) with advanced or metastatic colorectal cancer (MCRC)

被引：0
|
作者：
Maroun, Jean A. [1 ]
Jonker, Derek [1 ]
Goel, Rakesh [1 ]
Cripps, Christine [1 ]
Lister, Diane [1 ]
Chiritescu, Gabriela [1 ]
机构：
[1] Ottawa Hosp, Reg Canc Ctr, Ottawa, ON, Canada
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [21] A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
    Vasile, E.
    Masi, G.
    Fornaro, L.
    Cupini, S.
    Loupakis, F.
    Bursi, S.
    Petrini, I.
    Di Donato, S.
    Brunetti, I. M.
    Ricci, S.
    Antonuzzo, A.
    Chiara, S.
    Amoroso, D.
    Andreuccetti, M.
    Falcone, A.
    BRITISH JOURNAL OF CANCER, 2009, 100 (11) : 1720 - 1724
  • [22] A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
    E Vasile
    G Masi
    L Fornaro
    S Cupini
    F Loupakis
    S Bursi
    I Petrini
    S Di Donato
    I M Brunetti
    S Ricci
    A Antonuzzo
    S Chiara
    D Amoroso
    M Andreuccetti
    A Falcone
    British Journal of Cancer, 2009, 100 : 1720 - 1724
  • [23] Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis
    R Zarate
    J Rodríguez
    E Bandres
    A Patiño-Garcia
    M Ponz-Sarvise
    A Viudez
    N Ramirez
    N Bitarte
    A Chopitea
    J Gacía-Foncillas
    British Journal of Cancer, 2010, 102 : 987 - 994
  • [24] Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis
    Zarate, R.
    Rodriguez, J.
    Bandres, E.
    Patino-Garcia, A.
    Ponz-Sarvise, M.
    Viudez, A.
    Ramirez, N.
    Bitarte, N.
    Chopitea, A.
    Gacia-Foncillas, J.
    BRITISH JOURNAL OF CANCER, 2010, 102 (06) : 987 - 994
  • [25] Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer
    Bajetta, E.
    Celio, L.
    Ferrario, E.
    Di Bartolomeo, M.
    Denaro, A.
    Dotti, K.
    Mancin, M.
    Bajetta, R.
    Colombo, A.
    Pusceddu, S.
    ANNALS OF ONCOLOGY, 2007, 18 (11) : 1810 - 1816
  • [26] Oxaliplatin, Irinotecan and Capecitabine (OCX) for First-Line Treatment of Advanced/Metastatic Colorectal Cancer: A Phase I Trial (SAKK 41/03)
    von Moos, Roger
    Roth, Arnaud
    Ruhstaller, Thomas
    Widmer, Lucas
    Uhlmann, Catrina
    Cathomas, Richard
    Koeberle, Dieter
    Simcock, Mathew
    Lanz, Doris
    Popescu, Razvan
    ONKOLOGIE, 2010, 33 (06): : 295 - 299
  • [27] Phase I study of docetaxel, oxaliplatin, and capecitabine as first-line therapy to patients with advanced gastroesophageal cancer
    Schonnemann, K. R.
    Andersen, M.
    Yilmaz, M.
    Jensen, H. A.
    Vestermark, L. W.
    Pfeiffer, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study
    Tewes, M
    Schleucher, N
    Achterrath, W
    Wilke, HJ
    Frings, S
    Seeber, S
    Harstrick, A
    Rustum, YM
    Vanhoefer, U
    ANNALS OF ONCOLOGY, 2003, 14 (09) : 1442 - 1448
  • [29] Phase II study of capecitabine plus oxaliplatin (XELOX) followed by capecitabine plus irinotecan (XELIRI) in a sequential schedule in first-line metastatic colorectal cancer (MCRC)
    Cassinello, Javier
    Alvarez, Jose V.
    Garcia Lopez, Maria J.
    Pujol, Eduardo
    Colmenarejo, Antonio
    De Segovia, Fernando
    Marcos, Fernando
    Filipovich, Elena
    Arcediano, Alberto
    Garcia Castro, Ines
    ANNALS OF ONCOLOGY, 2006, 17 : 116 - 117
  • [30] Phase I/II Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer
    Doi, Toshihiko
    Boku, Narikazu
    Kato, Ken
    Komatsu, Yoshito
    Yamaguchi, Kensei
    Muro, Kei
    Hamamoto, Yasuo
    Sato, Atsushi
    Koizumi, Wasaburo
    Mizunuma, Nobuyuki
    Takiuchi, Hiroya
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (10) : 913 - 920
12345